These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 301599)

  • 1. [A case of active chronic hepatitis with antimicrosomal and antinuclear antibodies].
    Marchesini G; Masi M; Paolucci P; Franceschi C; Perocco P; Zauli D
    Minerva Pediatr; 1977 Apr; 29(12):827-32. PubMed ID: 301599
    [No Abstract]   [Full Text] [Related]  

  • 2. [Autoantibodies in liver diseases: interpretation and pathogenic importance].
    Pons Romero F; Casafont F
    Gastroenterol Hepatol; 1996; 19(6):326-33. PubMed ID: 8754423
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunopathogenesis of chronic inflammatory liver diseases].
    Meyer zum Büschenfelde
    Ergeb Inn Med Kinderheilkd; 1972; 32():31-81. PubMed ID: 4556562
    [No Abstract]   [Full Text] [Related]  

  • 4. [Quantitative alterations of the immunoglobuline classes and the presence of autoantibodies in liver diseases (author's transl)].
    Ossena A; Gola F; Raho L; Taroni G
    Quad Sclavo Diagn; 1978 Sep; 15(3):316. PubMed ID: 379904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic active hepatitis with antibodies against liver and kidney microsomes].
    Volta U; Ballardini G; Cassani F; Zauli D; Bianchi FB; Pisi E
    Med Chir Dig; 1980; 9(6):465-9. PubMed ID: 7206856
    [No Abstract]   [Full Text] [Related]  

  • 6. [The microsomal antibody (LKM) in liver pathology: its association with other autoantibodies].
    Ruffatti A; Chiaramonte M; Sebastianelli A; Naccarato R
    Boll Ist Sieroter Milan; 1980 Sep; 59(4):359-65. PubMed ID: 6970582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsomal antibodies in active chronic hepatitis and other disorders.
    Rizzetto M; Swana G; Doniach D
    Clin Exp Immunol; 1973 Nov; 15(3):331-44. PubMed ID: 4587503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Generalized scleroderma associated at with active chronic hepatitis. Successive apparition of different serum antibodies].
    Husson JM; Petite JP; Homberg JC; Lunel J; Audebert A; Camilleri JP
    Nouv Presse Med; 1974 Dec; 3(45):2717-21. PubMed ID: 4549263
    [No Abstract]   [Full Text] [Related]  

  • 10. [Active chronic hepatitis].
    Cachin M; Launois JP
    Nouv Presse Med; 1972 Jul; 1(27):1821-2. PubMed ID: 4537764
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of autoantibodies in the diagnosis of non-A, non-B hepatitis].
    Manns M; Arnold W; Meyer zum Büschenfelde KH
    Leber Magen Darm; 1984 Sep; 14(5):211-5. PubMed ID: 6436603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoantibodies and Australia antigen in acute and chronic liver].
    Fargion SR; Del Ninno E; Cappellini MD; Fiorelli G
    Minerva Med; 1974 Feb; 65(13):723-8. PubMed ID: 4545217
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic disorders associated with liver-kidney microsomal antibodies.
    Smith MG; Williams R; Walker G; Rizzetto M; Doniach D
    Br Med J; 1974 Apr; 2(5910):80-4. PubMed ID: 4596402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinuclear and smooth muscle antibodies in chronic hepatitis.
    Fodor I; Dejica D
    Rev Roum Med Intern; 1972; 9(3):257-63. PubMed ID: 4570802
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anatoma-clinical correlations in patients with liver diseases with circulating antibodies studied in regional case records].
    Verme G; Rizzetto M; Crivelli O; Bonino F
    Minerva Gastroenterol; 1976; 22(3):219-26. PubMed ID: 187986
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of anti-tissue antibodies in the evolution of chronic liver diseases].
    Buligescu L; Moscaliuc I; Eşanu I; Ionică M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(6):445-52. PubMed ID: 6121363
    [No Abstract]   [Full Text] [Related]  

  • 17. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.
    Clifford BD; Donahue D; Smith L; Cable E; Luttig B; Manns M; Bonkovsky HL
    Hepatology; 1995 Mar; 21(3):613-9. PubMed ID: 7533120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrosomal antibodies, gastric parietal cell antibodies and antinuclear factors in insulin dependent diabetes mellitus.
    Nagaoka K; Sakurami T; Nabeya N; Imura H; Kuno S
    Endocrinol Jpn; 1979 Oct; 26(5):599-603. PubMed ID: 393506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of immune histological findings for indication of immunosuppressive therapy in chronic aggressive hepatitis].
    Storch W; Emmrich R; Petzold H
    Z Gesamte Inn Med; 1973 Jun; 28(11):Suppl:174-6. PubMed ID: 4580507
    [No Abstract]   [Full Text] [Related]  

  • 20. [Heterogeneity of antimicrosomal autoantibodies in chronic hepatitis C virus infection and delta hepatitis].
    Durazzo M; Costa C; Schmidt E; Loges S; Scaglione L; Touscoz AG; Smedile A; Manns MP; Rizzetto M; Pagano G
    Ann Ital Med Int; 1995; 10(2):93-7. PubMed ID: 7542466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.